25 is the total number of securities Euclidean Capital LLC has owned. The longest Euclidean Capital LLC has owned a single stock is 12 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| PMVP | PMV PHARMACEUTICALS INC | 12 | 12 | 3.52% | 27.78% | 54.42% | Q4 2020 | Q3 2023 | 12 |
| FHTX | FOGHORN THERAPEUTICS INC | 12 | 12 | 1.72% | 7.92% | 16.40% | Q4 2020 | Q3 2023 | 12 |
| NGM | NGM BIOPHARMACEUTICALS... | 12 | 12 | 0.23% | 7.02% | 14.52% | Q4 2020 | Q3 2023 | 12 |
| ALEC | ALECTOR INC | 12 | 12 | 1.52% | 6.76% | 11.52% | Q4 2020 | Q3 2023 | 12 |
| RAPT | RAPT THERAPEUTICS INC | 12 | 12 | 2.39% | 6.40% | 9.67% | Q4 2020 | Q3 2023 | 12 |
| ORIC | ORIC PHARMACEUTICALS INC | 12 | 12 | 1.31% | 4.68% | 10.04% | Q4 2020 | Q3 2023 | 12 |
| TENAYA THERAPEUTICS INC | 9 | 9 | 0.56% | 4.24% | 9.87% | Q3 2021 | Q3 2023 | 9 | |
| FFBC | FIRST FINL BANCORP OH | 9 | 9 | 0.64% | 2.25% | 3.94% | Q4 2020 | Q4 2022 | 9 |
| SURROZEN INC | 9 | 9 | 0.11% | 1.31% | 2.94% | Q3 2021 | Q3 2023 | 9 | |
| ME | 23ANDME HOLDING CO | 7 | 7 | 2.18% | 17.08% | 27.20% | Q1 2022 | Q3 2023 | 7 |
| INDA | ISHARES TR | 4 | 4 | 22.54% | 28.66% | 41.45% | Q4 2022 | Q3 2023 | 4 |
| DNLI | DENALI THERAPEUTICS INC | 3 | 3 | 5.74% | 6.72% | 8.24% | Q4 2020 | Q2 2021 | 3 |
| CNST | CONSTELLATION PHARMCET... | 3 | 3 | 3.38% | 4.60% | 6.08% | Q4 2020 | Q2 2021 | 3 |
| VIR | VIR BIOTECHNOLOGY INC | 2 | 1 | 0.40% | 0.60% | 0.96% | Q1 2021 | Q4 2021 | 3 |
| PDD | PINDUODUO INC | 3 | 3 | 0.37% | 0.44% | 0.54% | Q1 2021 | Q3 2021 | 3 |
| GLD | SPDR GOLD TR | 2 | 2 | 25.42% | 32.59% | 39.75% | Q2 2023 | Q3 2023 | 2 |
| SPY | SPDR S&P 500 ETF TR | 2 | 2 | 22.97% | 25.51% | 28.05% | Q2 2023 | Q3 2023 | 2 |
| BEAM | BEAM THERAPEUTICS INC | 2 | 2 | 0.83% | 1.07% | 1.30% | Q1 2021 | Q2 2021 | 2 |
| COIN | COINBASE GLOBAL INC | 1 | 1 | 5.18% | 5.18% | 5.18% | Q1 2022 | Q1 2022 | 1 |
| SNOW | SNOWFLAKE INC | 1 | 1 | 3.70% | 3.70% | 3.70% | Q2 2021 | Q2 2021 | 1 |
| MQ | MARQETA INC | 1 | 1 | 2.42% | 2.42% | 2.42% | Q4 2021 | Q4 2021 | 1 |
| NRIX | NURIX THERAPEUTICS INC | 1 | 1 | 1.33% | 1.33% | 1.33% | Q2 2021 | Q2 2021 | 1 |
| RVMD | REVOLUTION MEDICINES INC | 1 | 1 | 0.78% | 0.78% | 0.78% | Q4 2020 | Q4 2020 | 1 |
| RUBY | RUBIUS THERAPEUTICS INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q1 2021 | Q1 2021 | 1 |
| SURROZEN INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2023 | Q3 2023 | 1 | |
Download | |||||||||
The securities at the top of the list , including PMV PHARMACEUTICALS INC, FOGHORN THERAPEUTICS INC, and NGM BIOPHARMACEUTICALS INC, are the highest-conviction holdings of Euclidean Capital LLC.
The conviction is calculated by counting the number of quarters a security has been reported by Euclidean Capital LLC. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Euclidean Capital LLC owns currently or has owned in the past.